JLABS Program Overview
Let’s get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC’s, Angels and other investment entities.
On June 18th, Kyle Rasbasch from Pappas Capital will present an overview of the fund, it’s investment strategy, primary areas of interest, and a few investment case studies. Following the presentation, they will meet 1-on-1 with companies that have been accepted after applying online.
*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due May 21, 2019. Apply Here.
About Pappas Capital
Since its founding in 1994, Pappas Capital has guided the launch and/or development of more than 70 life science companies, with a commitment to bringing promising products and technologies to market.
Pappas Capital invests exclusively in the life sciences sector – biotechnology, biopharmaceuticals, drug delivery, medical devices and related ventures – across the United States and Canada. The firm has raised more than $500 million across multiple funds, and has built a team with extensive experience in sourcing, evaluating, building and exiting life science companies. More than one-third of their 70 portfolio companies have successfully been acquired or completed initial public offerings.
To be considered for a 1-on-1 meeting complete the information required here. Applications due by May 21, 2019.